BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, July 12, 2026
View BioWorld MedTech
Home
» Clearcam sees quicker path to market with $2.6M series 2 seed round funding
To read the full story,
subscribe
or
sign in
.
Clearcam sees quicker path to market with $2.6M series 2 seed round funding
Aug. 12, 2020
By
Annette Boyle
Clearcam Inc.'s Kelling device has an improved view of the market thanks to the closing of a $2.6 million series 2 seed financing round, led by investor and entrepreneur Frank Barbella, CEO of Solv Risk Solutions.
Financings
Medical technology
Newco news
Minimally invasive surgery
